About AmorChem
AmorChem was established in 2011 in Westmount, Canada, as a venture capital firm. Investments are directed toward early-stage biotechnology companies. Funding, strategic guidance, and operational support are provided to portfolio firms in the biotech sector. The firm operates primarily from Canada, with decisions guided by experienced partners. Focus is maintained on therapeutic innovations and life sciences advancements, supporting company growth through targeted capital deployment.
- Headquarter Westmount, Canada
- Founders Elizabeth Douville, Ines Holzbaur
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
NuChem Therapeutics
(Feb 22, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AmorChem
Detailed funding history for AmorChem
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AmorChem
AmorChem has secured backing from 1 investor. Prominent investors backing the company include NuChem Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRO offering preclinical small molecule drug discovery services
|
Locked | Locked | Locked |
Investor details for AmorChem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AmorChem
Investment portfolio details for AmorChem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AmorChem
Detailed financials for AmorChem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amorchem Comparisons
Peer comparison for AmorChem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AmorChem
Detailed competitors of AmorChem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amorchem
Complete news archive for AmorChem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmorChem
AmorChem was founded in 2011.
AmorChem is headquartered in Westmount, Canada. It is registered at Westmount, Quebec, Canada.
AmorChem was established in 2011 in Westmount, Canada, as a venture capital firm. Investments are directed toward early-stage biotechnology companies. Funding, strategic guidance, and operational support are provided to portfolio firms in the biotech sector. The firm operates primarily from Canada, with decisions guided by experienced partners. Focus is maintained on therapeutic innovations and life sciences advancements, supporting company growth through targeted capital deployment.
AmorChem has 1 investor. Key investors include NuChem Therapeutics.